[Perspectives on modulation of chemoresistance of malignant diseases].
Allerödder
H P
HP
Medizinische Universitätsklinik, Innere Medizin V, Homburg/Saar.
Ukena
D
D
Sybrecht
G W
GW
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002352:Carrier Proteins / Q000235:genetics*; D002470:Cell Survival / Q000187:drug effects* / Q000235:genetics; D004351:Drug Resistance / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics*; D009369:Neoplasms / Q000188:drug therapy*; D014407:Tumor Cells, Cultured / Q000187:drug effects* / Q000378:metabolism
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D005978:Glutathione
Perspektiven zur Modulation der Chemoresistenz maligner Erkrankungen.